Expression of ICAM-1 in EpidermTM after treatment with a Novel Antisense Oligonucleotide (ISIS-2302)

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/01 → …

Funding

  • ISIS Pharmaceuticals: $19,000.00